GlassScriptPhysician profile
Arash Sarabi
NPI 1861693475
$1,109.88
in general payments reported to CMS, 2019-2025
13 companies · $382 in 2025
The $382 reported for 2025 was more than what 93% of Chiropractor providers received nationally (typical 2025 total: $40.91).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $174 · 2022: $517 · 2023: $37.25 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $419.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $364.14 | 2021-2022 | |
| Abbvie INC. | $207.65 | 2022-2025 | |
| Axsome Therapeutics, INC. | $121.84 | 2025 | Symbravo |
| Allergan, INC. | $100.80 | 2022 | |
| Abbott Laboratories | $81.21 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $68.83 | 2021 | |
| Aerin Medical INC. | $56.92 | 2025 | |
| Genentech USA, INC. | $20.25 | 2025 | Ocrevus Zunovo |
| Lundbeck LLC | $19.91 | 2023 | Vyepti |
| Supernus Pharmaceuticals, INC. | $19.23 | 2022 | |
| Currax Pharmaceuticals LLC | $17.84 | 2022 | |
| Impel Pharmaceuticals INC. | $17.34 | 2023 | Trudhesa |
| Ge Healthcare | $13.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arash Sarabi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.